as 02-21-2025 4:00pm EST
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Founded: | 1924 | Country: | United States |
Employees: | N/A | City: | WILMINGTON |
Market Cap: | 1.0B | IPO Year: | N/A |
Target Price: | $19.00 | AVG Volume (30 days): | 397.0K |
Analyst Decision: | Buy | Number of Analysts: | 2 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 0.99 | EPS Growth: | 2.96 |
52 Week Low/High: | $9.93 - $21.48 | Next Earning Date: | 02-06-2025 |
Revenue: | $1,107,700,000 | Revenue Growth: | -1.31% |
Revenue Growth (this year): | 0.26% | Revenue Growth (next year): | 1.24% |
EMBC Breaking Stock News: Dive into EMBC Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
Argus Research
4 days ago
GlobeNewswire
4 days ago
GuruFocus.com
16 days ago
MT Newswires
16 days ago
Zacks
16 days ago
GlobeNewswire
16 days ago
GlobeNewswire
16 days ago
The information presented on this page, "EMBC Embecta Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.